LEAP

BioCentriq, Inc.

Application Filed: 2023-05-05
Trademark Application Details
Trademark Logo LEAP

Mark For: LEAP™ trademark registration is intended to cover the categories of testing, research, development, and manufacturing of biopharmaceutical preparations for cell and gene therapy, including without limitation stem cell therapy; Scientific services, namely, testing, scientific research and development in the field of processes for cell and gene therapy, including without limitation stem cell therapy; stem cell research services and clinical research in the field of gene therapy; consulting services in the fields of biopharmaceutical research and development and genetic science.

Status

2023-05-09 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number97922999
Mark Literal ElementsLEAP
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeService Mark
Current LocationNEW APPLICATION PROCESSING 2023-05-09
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 100: Miscellaneous
  • 101: Advertising and Business
Primary International Class
  • 042 - Primary Class
  • (Computer, scientific & legal) Scientific and technological services and research and design relating thereto: industrial analysis and research services; design and development of computer hardware and software; legal services.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameAndrew D. Bochner
Attorney Docket Number1054.023TM

Timeline

2023-05-05Application Filed
2023-05-09Location: NEW APPLICATION PROCESSING
2023-05-09Status: Live/Pending
2023-05-09Status: New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information.
2023-05-09Transaction Date

Trademark Parties (Applicants & Owners)

Party: BioCentriq, Inc.
Address211 Warren Street Newark, NEW JERSEY UNITED STATES 07103
Legal Entity TypeCorporation
Legal Entity StateNEW JERSEY

Documents

Application2023-05-05
Drawing2023-05-05

Attorney of Record

ANDREW D. BOCHNER
BOCHNER IP, PLLC
295 MADISON AVE
12TH FLOOR
NEW YORK, NY 10017

Good, Services, and Codes

International Codes:42
U.S. Codes:100,101
Type CodeType
GS0421Testing, research, development, and manufacturing of biopharmaceutical preparations for cell and gene therapy, including without limitation stem cell therapy; Scientific services, namely, testing, scientific research and development in the field of processes for cell and gene therapy, including without limitation stem cell therapy; stem cell research services and clinical research in the field of gene therapy; consulting services in the fields of biopharmaceutical research and development and genetic science

Trademark Filing History

DescriptionDateProceeding Number
NEW APPLICATION ENTERED2023-05-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed